Literature DB >> 13708190

Blood radiation dose after 131-I therapy of thyrotoxicosis. Calculations with reference to leukaemia.

M GREEN, M FISHER, H MILLER, G M WILSON.   

Abstract

Entities:  

Keywords:  BLOOD/radiation effects; HYPERTHYROIDISM/therapy; IODINE/radioactive; LEUKEMIA/etiology; RADIOMETRY

Mesh：

Substances：

Year:  1961        PMID： 13708190      PMCID： PMC1969095          DOI： 10.1136/bmj.2.5246.210

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  26 in total

1.  Treatment of thyrotoxicosis with radioactive iodine; review of 140 cases.

Authors:  G W BLOMFIELD; J C JONES; H MILLER; A G MACGREGOR; E J WAYNE; R S WEETCH
Journal:  Br Med J       Date:  1955-11-19

2.  Association of irradiation with cancer of the thyroid in children and adolescents.

Authors:  D E CLARK
Journal:  J Am Med Assoc       Date:  1955-11-05

3.  Acute myeloid leukaemia after radioactive-iodine therapy.

Authors:  J D ABBATT; H E FARRAN; R GREENE
Journal:  Lancet       Date:  1956-05-26       Impact factor: 79.321

4.  Disappearance from serum of I131-labeled l-thyroxine and l-triiodothyronine in euthyroid subjects.

Authors:  K STERLING; J C LASHOF; E B MAN
Journal:  J Clin Invest       Date:  1954-07       Impact factor: 14.808

5.  Calculation of radioactive iodine beta radiation dose to the bone marrow.

Authors:  J S ROBERTSON; J T GODWIN
Journal:  Br J Radiol       Date:  1954-04       Impact factor: 3.039

6.  [Cancer of the thyroid treated with radioactive iodine; termination by acute leukemia after an important amelioration].

Authors:  J DELARUE; M TUBIANA; J DUTREIX
Journal:  Bull Assoc Fr Etud Cancer       Date:  1953

7.  The metabolic fate of I131 after large therapeutic doses in patients with metastatic carcinoma of the thyroid.

Authors:  J B STANBURY; G L BROWNELL; J BARZELATTO; J CORREA; J MAISTERRENA; J CORTAZAR; J RODRIGUEZ-SOTO
Journal:  J Clin Endocrinol Metab       Date:  1952-11       Impact factor: 5.958

8.  Dosimetric considerations in determining hematopoietic damage from radioactive iodine.

Authors:  J E RALL; C G FOSTER; J ROBBINS; R LAZERSON; L E FARR; R W RAWSON
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1953-08

9.  The urinary excretion of radioiodine as a clinical test of thyroid function.

Authors:  R FRASER; Q J G HOBSON; D G ARNOTT; E W EMERY
Journal:  Q J Med       Date:  1953-01

10.  British standard of radioactive iodine (131).

Authors:  E C BULLARD
Journal:  Nature       Date:  1952-11-29       Impact factor: 49.962
View more
  8 in total

1.  ACUTE LEUKAEMIA AFTER TREATMENT FOR HYPERTHYROIDISM WITH RADIOACTIVE IODINE.

Authors:  J A MCBRIDE
Journal:  Br Med J       Date:  1964-09-19

2.  THE LATE EFFECTS OF IRRADIATION--CLINICAL ASPECTS. RADIATION EXPOSURE FROM THE USE OF RADIOIODINE IN THYROID DISEASE.

Authors:  E E POCHIN
Journal:  Proc R Soc Med       Date:  1964-07

3.  THYROTOXICOSIS TREATED BY SURGERY OR IODINE-131. WITH SPECIAL REFERENCE TO DEVELOPMENT OF HYPOTHYROIDISM.

Authors:  M GREEN; G M WILSON
Journal:  Br Med J       Date:  1964-04-18

4.  CHROMOSOME ABERRATIONS AS A BIOLOGICAL DOSIMETER.

Authors:  S KELLY; C D BROWN
Journal:  Am J Public Health Nations Health       Date:  1965-09

5.  Benefits and risks in nuclear medicine.

Authors:  P C Johnson
Journal:  Am J Public Health       Date:  1972-12       Impact factor: 9.308

6.  Clinical trial of different doses of 131-I in treatment of thyrotoxicosis.

Authors:  R N Smith; G M Wilson
Journal:  Br Med J       Date:  1967-01-21

7.  Risks from radioiodine treatment of thyrotoxicosis.

Authors:  K E Halnan
Journal:  Br Med J (Clin Res Ed)       Date:  1983-12-17

8.  Is There Any Need for Adjusting 131I Activity for the Treatment of High Turnover Graves' Disease Compared to Normal Turnover Patients? Results from a Retrospective Cohort Study Validated by Propensity Score Analysis.

Authors:  Saurabh Arora; Chandrasekhar Bal
Journal:  Nucl Med Mol Imaging       Date:  2021-01-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.